Media Coverage

Back to Media Coverage

Bioverativ executive Rogerio Vivaldi to helm cell therapy producer Sigilon

Sigilon Therapeutics is bringing on Bioverativ’s chief global therapeutic operations officer, Rogerio Vivaldi, M.D., to serve as its CEO.